✦ LIBER ✦

Pharmacokinetic Disposition and Clinical Outcomes in Infants and Children Receiving Intravenous Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation

✍ Scribed by Tal Schechter; Yaron Finkelstein; John Doyle; Zulfikarali Verjee; Myla Moretti; Gideon Koren; L. Lee Dupuis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous busulfan for allogeneic hema

✍ Dalle, J H; Wall, D; Theoret, Y; Duval, M; Shaw, L; Larocque, D; Taylor, C; Gard 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Cyclophosphamide followed by Intravenous

✍ Rezvani, Andrew R.; McCune, Jeannine S.; Storer, Barry E.; Batchelder, Ami; Kida 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Pharmacokinetics and tolerability of int

✍ Yo-Han Cho; Hyun-Ae Lim; Mark Hong Lee; Inho Kim; Jong Seok Lee; Seong yang Park 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Intravenous Busulfan Pharmacokinetics in

✍ Bradley, Amber M.; Evans, Sarah; DeRemer, David; Awan, Farrukh Tauseef 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Association between Busulfan Exposure an

✍ Imke H. Bartelink; Robert G.M. Bredius; Svetlana V. Belitser; Marit M. Suttorp; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 589 KB

Relationship Between Intravenous Busulfa

✍ Keisler, Meredith D.; Simmons, Ashley E.; Ivanova, Anastasia; Walko, Christine M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 114 KB